par Vachiery, Jean-Luc 
Référence Advances in therapy, 28, 4, page (251-269)
Publication Publié, 2011-04
Référence Advances in therapy, 28, 4, page (251-269)
Publication Publié, 2011-04
Article révisé par les pairs
| Titre: |
|
| Auteur: | Vachiery, Jean-Luc |
| Informations sur la publication: | Advances in therapy, 28, 4, page (251-269) |
| Statut de publication: | Publié, 2011-04 |
| Sujet CREF: | Cardiologie et circulation |
| Mots-clés: | Beraprost |
| Epoprostenol | |
| Iloprost | |
| Prostacyclin | |
| Pulmonary arterial hypertension | |
| Treprostinil | |
| MeSH keywords: | Disease Management |
| Disease Progression | |
| Drug Delivery Systems | |
| Drug Therapy, Combination | |
| Exercise Tolerance -- drug effects | |
| Heart Failure -- etiology -- mortality -- therapy | |
| Humans | |
| Hypertension, Pulmonary -- complications -- mortality -- physiopathology -- therapy | |
| Lung -- blood supply | |
| Neovascularization, Physiologic -- drug effects | |
| Prostaglandins I -- administration & dosage -- adverse effects | |
| Pulmonary Circulation -- drug effects | |
| Vasodilator Agents -- administration & dosage -- adverse effects | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| SCOPUS: re.j | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0741-238X |
| info:doi/10.1007/s12325-011-0005-5 | |
| info:scp/79958189216 | |
| info:pmid/21455725 |
